Clinical trial: A randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 9, 2007, Pages 1251-1258

  Arts, J ^a   Holvoet, L ^a   Caenepeel, P ^a   Bisschops, R ^a   Sifrim, D ^a   Verbeke, K ^a   Janssens, J ^a   Tack, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PLACEBO; SODIUM CHLORIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; INJECTION; LIQUID; MALE; PRIORITY JOURNAL; PYLORUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOLID; STOMACH EMPTYING; STOMACH PARESIS; STUDENT T TEST; TREATMENT DURATION;

ADULT; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CROSS-OVER STUDIES; FEMALE; GASTRIC EMPTYING; GASTROPARESIS; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 35448956521     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03467.x     Document Type: Article

References (29)

1. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2005 127 : 1239 55.
2. Quartero A, de Wit N, Lodder A, et al. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998 43 : 2028.
3. Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003 98 : 783 8.
4. Parkman H, Hasler W, Fisher R. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004 127 : 1592 622.
5. Tack J. The difficult patient with gastroparesis. Best Pract Res Clin Gastroenterol 2007 21 : 379 91.
6. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006 4 : CD001960.
7. Sturm A, Holtmann G, Goebell H, Gerken G. Prokinetics in patients with gastroparesis: a systematic analysis. Digestion 1999 60 : 422 7.
8. Maganti K, Onyemere K, Jones M. Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. Am J Gastroenterol 2003 98 : 259 63.
9. Arts J, Sifrim D, Janssens J, Tack J. Erythromycin improves gastric emptying in dyspeptic patients with delayed gastric emptying but has no influence on symptoms. Gut 2005 54 : 455 60.
10. Abell T, McCallum R, Hocking M, Koch K, Abrahamsson H, Leblanc I, Lindberg G, Konturek J, Nowak T, Quigley EM, Tougas G, Starkebaum W. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003 125 : 421 8.
11. Fontana R, Barnett J. Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. Am J Gastroenterol 1996 91 : 2174 8.
12. Jones M, Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 2003 98 : 2122 9.
13. Gupta P, Rao SSC. Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report. Gastrointest Endosc 2002 56 : 770 2.
14. Lacy B, Zayat E, Crowel M, Schuster M. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 2002 97 : 1548 52.
15. Miller L, Szych G, Kantor S, Bromer M, Knight L, Maurer A, Fisher R, Parkman H. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002 97 : 1653 60.
16. Lacy B, Crowell M, Schettler-Duncan A, Mathis C, Pasricha P. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 2004 27 : 2341 7.
17. Bromer M, Friedenberg F, Miller L, Fisher R, Swartz K, Parkman H. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005 61 : 833 9.
18. Arts J, Van Gool S, Caenepeel P, Verbeke K, Janssens J, Tack J. Influence of intra-pyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther 2006 24 : 661 7.
19. Tougas G, Chen Y, Luo D, et al. Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms. Gastroenterology 2003 124 : A54 (abstract).
20. Ghoos Y, Maes B, Geypens B, et al. Measurement of gastric emptying rate of solids by means of a carbon labeled octanoic acid breath test. Gastroenterology 1993 104 : 1640 1647.
21. Maes B, Ghoos Y, Geypens B, et al. Combined carbon-13-glycin/carbon-14- octanoic acid breath test to monitor gastric emptying rates of liquids and solids. J Nucl Med 1994 35 : 824 31.
22. Ezzeddine D, Rajkamal J, Katz N, Gopalswamy M, Bhutani M. Pyloric injection of botulinum toxin for the treatment of diabetic gastroparesis. Gastrointest Endosc 2002 55 : 920 3.
23. Revicki D, Rentz A, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003 18 : 141 50.
24. Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000 14 : 1653 61.
25. Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, Mack RJ. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut 2001 49 : 395 401.
26. McCallum RW, Cynshi O, US INVESTIGATIVE TEAM. Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial. Aliment Pharmacol Ther 2007 26 : 107 16.
27. Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005 22 : 847 53.
28. Mearin F, Camilleri M, Malagelada J. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986 90 : 1919 25.
29. Shetler K, Nguyen LAB, Bunker S, Parker S, Snape WJ. Role of pyloric pressures and botulinum toxin (BT) injection in the treatment of diabetic (DM) and idiopathic gastroparesis (IG). Gastroenterology 2006, 130 : A-129 (abstract).